Mary Thompson

Executive Editor, MedTech Strategist

25 Years of Experience

About

A founding member of the MedTech Strategist editorial team, @MaryThompsonMTS has 25+ years of experience covering technologies and trends in the medical device industry. She currently focuses on the cardiovascular, diabetes, and digital health markets. Prior to joining MedTech Strategist, Mary was Managing Editor/Executive Editor of the Medtech Insight Newsletter, a position she held for nearly 14 years, and she was instrumental in the initial conceptualization and launch of that publication. Mary’s extensive editorial experience combined with her early background as an R&D scientist brings a unique balance of expertise and perspective to her work.

Specialties
Publications
Articles from Mary Thompson:
Read all from this author
Investors & Dealmaking

2025 Opens With a Flurry of Funding and an IPO

  • 2025-02-19 00:00:00.0
  • Mary Thompson
  • MedTech Strategist

Early indicators are positive for the medtech start-up community, with an uptick in funding deals and exits in the first weeks of the new year. Companies focused on heart failure (FIRE1, Alleviant Medical), neurology (Ceribell, Zeto, Saluda Medical), diabetes (Beta Bionics, CeQur), and AI solutions (Neko Health, Quibim) all gained ground recently. But longer-term uncertainties still loom, and the road ahead could be bumpy.

Read Article